Jump to ContentJump to Main Navigation

Online

249,00 € / $374.00*

* Prices subject to change. Shipping costs will be added if applicable.
Publication Date:
July 2012
ISSN:
1437-4315
DOI:
10.1515/hsz-2012-0115

See all formats and pricing

Online
Individual Subscription Online only
Euro [D] 249.00
RRP for USA, Canada, Mexico
US$ 374.00 *
Print
Individual Subscription Online only
Euro [D] 1566.00
RRP for USA, Canada, Mexico
US$ 2349.00 *
Print + Online
Individual Subscription Online only
Euro [D] 1880.00
RRP for USA, Canada, Mexico
US$ 2819.00 *
*Prices subject to change. Shipping costs will be added if applicable.

Editor-in-Chief: Brüne, Bernhard

Editorial Board Member: Ludwig, Stephan / Sies, Helmut / Stoffel, Markus / Turk, Boris / Wittinghofer, Alfred / Baumeister, Wolfgang / Bergeron, John / Bogyo, Matthew / Bürkle, Alexander / Cadenas, Enrique / Chiti, Fabrizio / Dikic, Ivan / Dobson, Christopher / Driessen, Arnold / Fritz, Hans / Gevaert, Kris / Hammann, Christian / Hartl, F. Ulrich / Häussinger, Dieter / Hiscott, John / Igarashi, Yasuyuki / Klotz, Lars-Oliver / Krüger, Achim / Magdolen, Viktor / Müschen, Markus / Narumiya, Shuh / Naumann, Michael / Pejler, Gunnar / Pfanner, Nikolaus / Pike, Robert / Potempa, Jan / Saftig, Paul / Sandhoff, Konrad / Schaffner, Walter / Sinning, Irmgard / Sommerhoff, Christian P.

12 Issues per year

IMPACT FACTOR 2011: 2.965
Rank 130 out of 289 in category Biochemistry and Molecular Biology in the 2011 Thomson Reuters Journal Citation Report/Science Edition

VolumeIssuePage

Issues

TDP-43 in central nervous system development and function: clues to TDP-43-associated neurodegeneration

1 / Basar Cenik1, 3 / Bercin Kutluk Cenik2 / Joachim Herz3 / 1

1Department of Neuroscience, The University of Texas Southwestern Medical Center at Dallas, 6000 Harry Hines Boulevard, Dallas, TX 75390-9111, USA

2Hamon Center for Therapeutic Oncology Research, The University of Texas Southwestern Medical Center at Dallas, 6000 Harry Hines Boulevard, Dallas, TX 75390-9111, USA

3Department of Molecular Genetics, The University of Texas Southwestern Medical Center at Dallas, 6000 Harry Hines Boulevard, Dallas, TX 75390-9111, USA

Corresponding authors

Citation Information: . Volume 393, Issue 7, Pages 589–594, ISSN (Online) 1437-4315, ISSN (Print) 1431-6730, DOI: 10.1515/hsz-2012-0115, July 2012

Publication History:
Received:
2012-01-30
Accepted:
2012-04-17

Abstract

From the earliest stages of embryogenesis and throughout life, transcriptional regulation is carefully orchestrated in order to generate, shape, and reshape the central nervous system (CNS). TAR DNA-binding protein 43 (TDP-43) is identified as a regulator of essential transcriptional events in the CNS. Evidence for its importance comes from the identification of TDP-43 protein aggregates and genetic mutations in patients with amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Efforts are being made to learn more about the biological function of TDP-43 and gain a better understanding of its role in neurodegeneration. TDP-43 RNA targets and protein interactions have now been identified, and in vivo evidence shows that TDP-43 is essential in CNS development and function. This review will highlight aspects of these findings.

Keywords: amyotrophic lateral sclerosis (ALS); neural development; PTPB2; RIP-seq; RNA binding protein; TDP-43

Comments (0)

Please log in or register to comment.